Individuals should have totally recovered in the acute harmful results of all prior anti-cancer therapy and ought to meet the subsequent minimal period from prior anti-cancer directed therapy previous to enrollment. Experimental: Dose expansion_sub-inhabitants 2_higher dose of niraparib MTDs and/or candidate RP2Ds for elimusertib applied together with niraparib at a https://acbi155432.affiliatblogger.com/78843476/how-obeticholic-acid-can-save-you-time-stress-and-money